FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women

Human Reproduction

Volumn 33, Issue 5, 2018, Pages 954-966

  Rull, Kristiina ^a,b   Grigorova, Marina ^a   Ehrenberg, Aivar ^a,b   Vaas, Pille ^a,b   Sekavin, Aire ^a   Nõmmemees, Diana ^a   Adler, Mart ^a   Hanson, Ele ^a,b   Juhanson, Peeter ^a   Laan, Maris ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

AMH in women; FSHB 211 G>T; FSHR 29 G>A; FSHR c.2039 A>G; genetics of gonadotropins; idiopathic female infertility; LH; serum FSH

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; FOLLITROPIN BETA SUBUNIT;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; FSHB GENE; FSHR GENE; GENE; GENETIC VARIABILITY; HEREDITY; HORMONE BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; REPRODUCTIVE HEALTH; ALLELE; BLOOD; CASE CONTROL STUDY; FERTILITY; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; PHENOTYPE; REPRODUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; ALLELES; ANTI-MULLERIAN HORMONE; CASE-CONTROL STUDIES; FEMALE; FERTILITY; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; MENSTRUAL CYCLE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCTION; YOUNG ADULT;

EID: 85047144574     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dey057     Document Type: Article

References (42)

1. Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, Mahale SD. Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism. Reprod Biomed Online 2009;18:509-515.
2. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P, Seliger E, Röpke F, Gromoll J, Nieschlag E et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005;15:451-456.
3. Benson CA, Kurz TL, Thackray VG. A human FSHB promoter SNP associated with low FSH levels in men impairs LHX3 binding and basal FSHB transcription. Endocrinology 2013;154:3016-3021.
4. Bliss SP, Navratil AM, Xie J, Roberson MS. GnRH signaling, the gonadotrope and endocrine control of fertility. Front Neuroendocrinol 2010;313: 322-340.
5. Busch AS, Kliesch S, Tüttelmann F, Gromoll J. FSHB -211 G>T stratification for follicle-stimulating hormone treatment of male infertility patients: making the case for a pharmacogenetic approach in genetic functional secondary hypogonadism. Andrology 2015;3:1050-1053.
6. Busch AS, Hagen CP, Almstrup K, Main KM, Juul A. Genetic variations altering FSH action affect circulating hormone levels as well as follicle growth in healthy peripubertal girls. Hum Reprod 2016;31:897-904.
7. Busch AS, Hagen CP, Assens M, Main KM, Almstrup K, Juul A. Differential impact of genetic loci on age at thelarche and menarche in healthy girls. J Clin Endocrinol Metab 2017. doi:10.1210/jc.2017-01860.
8. Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, Bjonnes A, Broer L, Dunger DB, Halldorsson BV et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun 2015;6:8464.
9. Ferlin A, Vinanzi C, Selice R, Garolla A, Frigo AC, Foresta C. Toward a pharmacogenetic approach to male infertility: polymorphism of folliclestimulating hormone β-subunit promoter. Fertil Steril 2011;96:1344-1349.
10. Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, Kiesel L, Simoni M. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 2005;90:4866-4872.
11. Grigorova M, Punab M, Ausmees K, Laan M. FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men. Hum Reprod 2008;23:2160-2166.
12. Grigorova M, Punab M, Poolamets O, Kelgo P, Ausmees K, Korrovits P, Vihljajev V, Laan M. Increased Prevalance of the -211 T allele of follicle stimulating hormone (FSH) beta subunit promoter polymorphism and lower serum FSH in infertile men. J Clin Endocrinol Metab 2010;95:100-108.
13. Grigorova M, Punab M, Zilaitiene B, Erenpreiss J, Ausmees K, Matulevičius V, Tsarev I, Jørgensen N, Laan M. Genetically determined dosage of follicle-stimulating hormone (FSH) affects male reproductive parameters. J Clin Endocrinol Metab 2011;96:E1534-E1541.
14. Grigorova M, Punab M, Poolamets O, Sober S, Vihljajev V, Žilaitiene B, Erenpreiss J, Matulevičius V, Tsarev I, Laan M. Study in 1790 Baltic men: FSHR Asn680Ser polymorphism affects total testes volume. Andrology 2013;1:293-300.
15. Grigorova M, Punab M, Punab AM, Poolamets O, Vihljajev V, Zilaitiene B, Erenpreiss J, Matulevičius V, Laan M. Reproductive physiology in young men is cumulatively affected by FSH-action modulating genetic variants: FSHR -29G/A and c.2039 A/G, FSHB -211G/T. PLoS One 2014;9:e94244.
16. Hagen CP, Aksglaede L, Sørensen K, Mouritsen A, Mieritz MG, Main KM, Petersen JH, Almstrup K, Rajpert-De Meyts E, Anderson RA et al. FSHB-211 and FSHR 2039 are associated with serum levels of folliclestimulating hormone and antimüllerian hormone in healthy girls: a longitudinal cohort study. Fertil Steril 2013;100:1089-1095.
17. Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R, Karaderi T, Barber TM, McCarthy MI, Franks S et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun 2015;6:7502.
18. Henriksen LS, Hagen CP, Assens M, Busch AS, Skakkebæk NE, Almstrup K, Main KM. Genetic variations in FSH action affect sex hormone levels and breast tissue size in infant girls: a pilot study. J Clin Endocrinol Metab 2016;101:3191-3198.
19. Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, Buckland PR, O'Donovan MC. Functional analysis of human promoter polymorphisms. Hum Mol Genet 2003;12:2249-2254.
20. La Marca A, Papaleo E, Alviggi C, Ruvolo G, De Placido G, Candiani M, Cittadini E, De Michele F, Moriondo V, Catellani V et al. The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age. Hum Reprod 2013;28:1369-1374.
21. Laan M, Grigorova M, Huhtaniemi IT. Pharmacogenetics of folliclestimulating hormone action. Curr Opin Endocrinol, Diabetes Obes 2012; 19:220-227.
22. Lee JE, Yoon SH, Kim HO, Min EG. Correlation between the serum luteinizing hormone to follicle stimulating hormone ratio and the anti- Müllerian hormone levels in normo-ovulatory women. J Korean Med Sci 2015;30:296-300.
23. Mbarek H, Steinberg S, Nyholt DR, Gordon SD, Miller MB, McRae AF, Hottenga JJ, Day FR, Willemsen G, de Geus EJ et al. Identification of common genetic variants influencing spontaneous dizygotic twinning and female fertility. Am J Hum Genet 2016;98:898-908.
24. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000;85: 3365-3369.
25. Punab M, Poolamets O, Paju P, Vihljajev V, Pomm K, Ladva R, Korrovits P, Laan M. Causes of male infertility: a 9-year prospective monocentre study on 1737 patients with reduced total sperm counts. Hum Reprod 2017;32:18-31.
26. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
27. Riccetti L, De Pascali F, Gilioli L, Santi D, Brigante G, Simoni M, Casarini L. Genetics of gonadotropins and their receptors as markers of ovarian reserve and response in controlled ovarian stimulation. Best Pract Res Clin Obstet Gynaecol 2017;44:15-25.
28. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
29. Ruth KS, Beaumont RN, Tyrrell J, Jones SE, Tuke MA, Yaghootkar H, Wood AR, Freathy RM, Weedon MN, Frayling TM et al. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health. Hum Reprod 2016a;31:473-481.
30. Ruth KS, Campbell PJ, Chew S, Lim EM, Hadlow N, Stuckey BG, Brown SJ, Feenstra B, Joseph J, Surdulescu GL et al. Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes. Eur J Hum Genet 2016b;24:284-290.
31. Sapkota Y, Steinthorsdottir V, Morris AP, Fassbender A, Rahmioglu N, De Vivo I, Buring JE, Zhang F, Edwards TL, Jones S et al. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nat Commun 2017;8:15539.
32. Schóring AN, Busch AS, Bogdanova N, Gromoll J, Tóttelmann F. Effects of the FSH-β-subunit promoter polymorphism -211G->T on the hypothalamic-pituitary-ovarian axis in normally cycling women indicate a gender-specific regulation of gonadotropin secretion. J Clin Endocrinol Metab 2013;98:E82-E86.
33. Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, Zhang B, Liang X, Li T, Chen J et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet 2012;44:1020-1025.
34. Simoni M, Casarini L. Mechanisms in endocrinology: genetics of FSH action: a 2014-and-beyond view. Eur J Endocrinol 2014;170:91-107.
35. Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, Baird DD. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. J Am Med Assoc 2017;318:1367-1376.
36. Tamburino L, La Vignera S, Tomaselli V, Condorelli RA, Cannarella R, Mongioì LM, Calogero AE. The -29G/A FSH receptor gene polymorphism is associated with higher FSH and LH levels in normozoospermic men. J Assist Reprod Genet 2017;34:1289-1294.
37. Tian Y, Zhao H, Chen H, Peng Y, Cui L, Du Y, Wang Z, Xu J, Chen ZJ. Variants in FSHB are associated with polycystic ovary syndrome and luteinizing hormone level in Han Chinese women. J Clin Endocrinol Metab 2016;101:2178-2184.
38. Tüttelmann F, Laan M, Grigorova M, Punab M, Sober S, Gromoll J. Combined effects of the variants FSHB -211 G>T and FSHR 2039A>G on male reproductive parameters. J Clin Endocrinol Metab 2012;97: 3639-3647.
39. World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen, 5th edn. Geneva: World Health Organization, 2010.
40. Wunsch A, Ahda Y, Banaz-Yašar F, Sonntag B, Nieschlag E, Simoni M, Gromoll J. Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor. Fertil Steril 2005;84:446-453.
41. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genomewide complex trait analysis. Am J Hum Genet 2011;88:76-82.
42. Yao Y, Ma CH, Tang HL, Hu YF. Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and invitro fertilization outcome: a meta-analysis. Mol Genet Metab 2011;103: 388-393.